Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy

NCT00264368 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Acute Renal Failure
Cytomegalovirus Infections
Multi Organ Failure

Interventions

DRUG: intravenous (IV) ganciclovir

Sponsor

University of Oslo School of Pharmacy